Clinical Trial Update: Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor) [Phase 2]

View source ↗

Summary

Phase 2 trial update for cilengitide in recurrent glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• cilengitide (cilengitide)

Snippet

Sponsor: EMD Serono | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16